Henry Calvert shared the sweet moment he told his grandma, Baba, that they were heading on a surprise trip to Disneyland ...

On Tuesday, Wrexham will face Cardiff for the first time in 21 years – a lot has changed at the two clubs since their last ...

Follow the team through Day 2 of their Bike Parkour filming adventure. From testing new routes and improving stunts to ...

Join me for a day biking through Central Park in New York City. This vlog captures the beauty of the park’s paths, lakes, and skyline views while showing the best way to experience NYC on two wheels.

(Reuters) -Drugmaker Bristol Myers Squibb said on Friday it will acquire privately held cell therapy developer Orbital Therapeutics for $1.5 billion in cash. The deal adds to Bristol's CAR T-cell ...

Oct 10 (Reuters) - Drugmaker Bristol Myers Squibb (BMY.N), opens new tab said on Friday it will acquire privately held cell therapy developer Orbital Therapeutics for $1.5 billion in cash, aiming to ...

Bosses at the Bristol Beacon cancelled an event launching a campaign calling for Bristol Zoo to reopen, hours after private pressure from bosses at the zoo - and then tried to cover it up, Bristol ...

Bristol Myers Squibb (BMY) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the ...

BRISTOL, Va. (WJHL) — A Bristol, Virginia, woman was charged in connection with an ongoing child abuse investigation on Thursday. Jameeka Starks, 33, was charged with abuse and neglect of a child and ...

Bhad Bhabie recently launched a vlog series on YouTube, and the latest episode has offered an unfiltered look at the complicated relationship between her and the father of her child. In the second ...

Bristol Bears have signed experienced Argentina international Matias Moroni on a short-term deal. The 34-year-old - who can play on the wing and centre - comes in as extra cover following a number of ...

BMS will acquire Orbital Therapeutics and its CAR T-cell therapy OTX-201 to diversify its cell therapy portfolio. The acquisition involves a $1.5 billion cash transaction, subject to customary closing ...